V. Carreau

发表

Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP.

P. Giral, E. Bruckert, L. Leenhardt, 2004, Atherosclerosis.

Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients.

E. Bruckert, C. Jublanc, J. Kahn, 2009, Atherosclerosis.

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

M. Krempf, G. Luc, P. Hopkins, 2015, Circulation. Cardiovascular genetics.

Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia.

P. Cluzel, A. Redheuil, M. Maranghi, 2017, Journal of clinical lipidology.

Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patients.

P. Giral, E. Bruckert, C. Dourmap, 2007, Atherosclerosis.

High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.

M. Krempf, J. Ferrières, E. Bruckert, 2018, Atherosclerosis.

Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects.

M. Krempf, G. Luc, J. Ferrières, 2014, Atherosclerosis.

Long-Term Follow-Up of Statin Treatment in a Cohort of Children with Familial Hypercholesterolemia

E. Bruckert, J. Girardet, V. Carreau, 2011, Paediatric drugs.

Cognitive function in adult adrenoleukodystrophy: comparison with leukoaraiosis and multiple sclerosis.

N. Baumann, E. Cabanis, A. Tourbah, 1991, Developmental neuroscience.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia.

A. Prat, N. Seidah, J. Michel, 2012, Atherosclerosis.

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed‐forward loop between LXR and autophagy

J. Borén, S. Humphries, A. Smit, 2019, Journal of internal medicine.

Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France

A. Munnich, C. Junien, C. Boileau, 2010, Human mutation.

APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia

J. Ferrières, A. Philippi, P. Giral, 2022, International journal of molecular sciences.

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.

E. Bruckert, D. Bonnefont-Rousselot, D. Rosenbaum, 2017, Atherosclerosis.

Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?

G. Luc, E. Bruckert, C. Boileau, 2018, European Journal of Human Genetics.

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia

M. Krempf, V. Rigalleau, J. Ferrières, 2022, Atherosclerosis plus.

Adult forms of metachromatic leukodystrophy: clinical and biochemical approach.

N. Baumann, N. Herschkowitz, M. Masson, 1991, Developmental neuroscience.

Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study

S. Humphries, A. Smit, R. Rauramaa, 2020, Genes & Immunity.

New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia

G. Peloso, N. Stitziel, E. Bruckert, 2018, Scientific Reports.

SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.

M. Krempf, J. Ferrières, P. Giral, 2020, Atherosclerosis.

Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome

J. C. Wolters, A. von Eckardstein, L. Rohrer, 2021, Circulation research.

Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study

S. Humphries, A. Smit, R. Rauramaa, 2020, Genes & Immunity.

Use of an indirect effect model to describe the LDL cholesterol‐lowering effect by statins in hypercholesterolaemic patients

S. Urien, J. Hulot, P. Giral, 2006, Fundamental & clinical pharmacology.

[Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases].

N. Baumann, B. Fontaine, O. Gout, 1993, Revue neurologique.

Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia

P. Moulin, F. Paillard, B. Cariou, 2023, Arteriosclerosis, thrombosis, and vascular biology.

The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.

G. Luc, E. Bruckert, A. Millier, 2016, Journal of clinical lipidology.

Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia

J. Lecerf, B. Coulombe, J. Ferrières, 2022, Metabolites.

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study

P. Cluzel, A. Redheuil, N. Kachenoura, 2021, EBioMedicine.

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed‐forward loop between LXR and autophagy

J. Borén, S. Humphries, A. Smit, 2019, Journal of internal medicine.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.

Arteriosclerosis, Thrombosis, and Vascular Biology.

A. Inoue, M. Varret, T. Worgall, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia.

P. Cluzel, A. Redheuil, M. Maranghi, 2017, Journal of clinical lipidology.

Arteriosclerosis, Thrombosis, and Vascular Biology.

M. Varret, Arterioscler Thromb, Vasc Biol, 2016, Arteriosclerosis, thrombosis, and vascular biology.